ATXA Therapeutics is Drug Discovery in Ireland that focus on blood vessel remodeling business. Founded in 2015. They cover business area such as developer, novel small molecule drug, Pulmonary Arterial Hypertension, (PAH, backup candidate, an alternative approach, improved vasodilation, TX, inflammation, fibrosis, blood vessel remodeling, thrombosis, PAH patient, a proper line, treatment, cure.
2015
( 11 years old in 2026 )
Blood Vessel Remodeling
-
Conway Institute Biomolecular & Biomedical Research
University College Dublin, Belfield, Dublin 4
Dublin
Ireland
Private
developernovel small molecule drugPulmonary Arterial Hypertension(PAHbackup candidatean alternative approachimproved vasodilationTXinflammationfibrosisblood vessel remodelingthrombosisPAH patienta proper linetreatmentcure
* We use standard office opening hours in near ATXA Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ATXA Therapeutics is Drug Discovery business from Ireland that founded in 2015 (11 years old in 2026), ATXA Therapeutics business is focusing on Blood Vessel Remodeling.
ATXA Therapeutics headquarter office and corporate office address is located in Conway Institute Biomolecular & Biomedical Research University College Dublin, Belfield, Dublin 4 Dublin Ireland.
ATXA Therapeutics was founded in Ireland.
In 2026, ATXA Therapeutics is currently focus on blood vessel remodeling sector.
Above is snippet of Google Trends for "blood vessel remodeling" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ATXA Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
